These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29641707)

  • 21. Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography.
    Byers RA; Maiti R; Danby SG; Pang EJ; Mitchell B; Carré MJ; Lewis R; Cork MJ; Matcher SJ
    Biomed Opt Express; 2018 Apr; 9(4):2001-2017. PubMed ID: 29675335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab.
    Thomsen SF
    J Dermatolog Treat; 2018 Dec; 29(8):823-824. PubMed ID: 29671663
    [No Abstract]   [Full Text] [Related]  

  • 23. Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis.
    Takemura M; Nakahara T; Hashimoto-Hachiya A; Furue M; Tsuji G
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult atopic dermatitis: new and emerging therapies.
    Napolitano M; Marasca C; Fabbrocini G; Patruno C
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):867-878. PubMed ID: 30073901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
    Pescitelli L; Rosi E; Ricceri F; Pimpinelli N; Prignano F
    Curr Pharm Biotechnol; 2021; 22(1):73-84. PubMed ID: 32525769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study.
    Deleuran M; Thaçi D; Beck LA; de Bruin-Weller M; Blauvelt A; Forman S; Bissonnette R; Reich K; Soong W; Hussain I; Foley P; Hide M; Bouaziz JD; Gelfand JM; Sher L; Schuttelaar MLA; Wang C; Chen Z; Akinlade B; Gadkari A; Eckert L; Davis JD; Rajadhyaksha M; Staudinger H; Graham NMH; Pirozzi G; Ardeleanu M
    J Am Acad Dermatol; 2020 Feb; 82(2):377-388. PubMed ID: 31374300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017/2018.
    Werfel T
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):432-437. PubMed ID: 30095475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New and Emerging Systemic Treatments for Atopic Dermatitis.
    Newsom M; Bashyam AM; Balogh EA; Feldman SR; Strowd LC
    Drugs; 2020 Jul; 80(11):1041-1052. PubMed ID: 32519223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of biologics in atopic dermatitis.
    Wu J; Guttman-Yassky E
    Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.
    Worm M; Simpson EL; Thaçi D; Bissonnette R; Lacour JP; Beissert S; Kawashima M; Ferrándiz C; Smith CH; Beck LA; Chan KC; Chen Z; Akinlade B; Hultsch T; Staudinger H; Gadkari A; Eckert L; Davis JD; Rajadhyaksha M; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Ardeleanu M
    JAMA Dermatol; 2020 Feb; 156(2):131-143. PubMed ID: 31876900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
    Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
    J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
    Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
    Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative efficacy of systemic treatments for atopic dermatitis.
    Seger EW; Wechter T; Strowd L; Feldman SR
    J Am Acad Dermatol; 2019 Feb; 80(2):411-416.e4. PubMed ID: 30296535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atopic dermatitis.
    Weidinger S; Beck LA; Bieber T; Kabashima K; Irvine AD
    Nat Rev Dis Primers; 2018 Jun; 4(1):1. PubMed ID: 29930242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Not Available].
    Chiricozzi A; Costanzo A; Levi A; Parretta F; Ravasio R
    Glob Reg Health Technol Assess; 2024; 11():38-50. PubMed ID: 38380163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pterostilbene reduces the progression of atopic dermatitis via modulating inflammatory and oxidative stress biomarkers in mice.
    Bangash Y; Saleem A; Akhtar MF; Anwar F; Akhtar B; Sharif A; Khan MI; Khan A
    Inflammopharmacology; 2023 Jun; 31(3):1289-1303. PubMed ID: 37069463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric Nanoparticles as Tunable Nanocarriers for Targeted Delivery of Drugs to Skin Tissues for Treatment of Topical Skin Diseases.
    Madawi EA; Al Jayoush AR; Rawas-Qalaji M; Thu HE; Khan S; Sohail M; Mahmood A; Hussain Z
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Not Available].
    Costanzo A; Furneri G; Bitonti R; Pedone MP; Fanelli F; Di Turi R
    Glob Reg Health Technol Assess; 2020; 7():57-65. PubMed ID: 36627954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.
    Rogner D; Biedermann T; Lauffer F
    Acta Derm Venereol; 2022 Mar; 102():adv00677. PubMed ID: 35083493
    [No Abstract]   [Full Text] [Related]  

  • 40. Osthole Inhibits Expression of Genes Associated with Toll-like Receptor 2 Signaling Pathway in an Organotypic 3D Skin Model of Human Epidermis with Atopic Dermatitis.
    Kordulewska NK; Topa J; Stryiński R; Jarmołowska B
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.